Meta-Analysis: The Relationship Between CTLA-4 +49 A/G Polymorphism and Primary Biliary Cirrhosis and Type I Autoimmune Hepatitis

References

• Agarwal K, Czaja AJ, Jones DE, Donaldson PT. (2000a). Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology, 31, 49–53
   PubMed Web of Science ®Google Scholar
• Agarwal K, Jones DE, Daly AK, et al. (2000b). CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol, 32, 538–41
   PubMed Web of Science ®Google Scholar
• Aiba Y, Nakamura M, Joshita S, et al. (2011). Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients. J Gastroenterol, 46, 1203–12
   PubMed Web of Science ®Google Scholar
• Alvarez-Quiroga C, Abud-Mendoza C, Doniz-Padilla L, et al. (2011). CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis. J Clin Immunol, 31, 588–95
   PubMed Web of Science ®Google Scholar
• Bittencourt PL, Palacios SA, Cancado EL, et al. (2003a). Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am J Gastroenterol, 98, 1616–20
   PubMed Web of Science ®Google Scholar
• Bittencourt PL, Palacios SA, Farias AQ, et al. (2003b). Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J Gastroenterol Hepatol, 18, 1061–6
   PubMed Web of Science ®Google Scholar
• Chang WW, Zhang L, Yao YS, Su H. (2012). Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: An updated analysis. Mol Biol Rep, 39, 9159–65
   PubMed Web of Science ®Google Scholar
• Chen RR, Han ZY, Li JG, et al. (2011). Cytotoxic T-lymphocyte antigen 4 gene +49A/G polymorphism significantly associated with susceptibility to primary biliary cirrhosis: A meta-analysis. J Dig Dis, 12, 428–35
   PubMed Web of Science ®Google Scholar
• Chen Z, Fei M, Fu D, et al. (2013). Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: A meta-analysis. Gene, 516, 263–70
   PubMed Web of Science ®Google Scholar
• Cutolo M, Nadler SG. (2013). Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis. Autoimmun Rev, 12, 758–67
   PubMed Web of Science ®Google Scholar
• Dhirapong A, Yang GX, Nadler S, et al. (2013). Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology, 57, 708–15
   PubMed Web of Science ®Google Scholar
• Djilali-Saiah I, Ouellette P, Caillat-Zucman S, et al. (2001). CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis. Hum Immunol, 62, 1356–62
   PubMed Web of Science ®Google Scholar
• Donaldson P, Veeramani S, Baragiotta A, et al. (2007). Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin Gastroenterol Hepatol, 5, 755–60
   PubMed Web of Science ®Google Scholar
• Downie-Doyle S, Bayat N, Rischmueller M, Lester S. (2006). Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjogren's syndrome. Arthritis Rheum, 54, 2434–40
   PubMed Web of Science ®Google Scholar
• Duclos-Vallee JC, Sebagh M. (2009). Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation. Liver Transpl, 15, S25–34
   PubMed Web of Science ®Google Scholar
• Eskandari-Nasab E, Moghadampour M, Najibi H, Hadadi-Fishani M. (2014). Investigation of CTLA-4 and CD86 gene polymorphisms in Iranian patients with brucellosis infection. Microbiol Immunol, 58, 135–41
   PubMed Web of Science ®Google Scholar
• Fan LY, Tu XQ, Cheng QB, et al. (2004). Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J Gastroenterol, 10, 3056–9
   PubMed Web of Science ®Google Scholar
• Geier MR, Geier DA. (2004). A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: Analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol, 22, 749–55
   PubMed Web of Science ®Google Scholar
• Homann D, Dummer W, Wolfe T, et al. (2006). Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J Virol, 80, 270–80
   PubMed Web of Science ®Google Scholar
• Joshita S, Umemura T, Yoshizawa K, et al. (2010). Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients. J Hepatol, 53, 537–41
   PubMed Web of Science ®Google Scholar
• Juran BD, Atkinson EJ, Schlicht EM, et al. (2008a). Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology, 47, 563–70
   PubMed Web of Science ®Google Scholar
• Juran BD, Atkinson EJ, Schlicht EM, et al. (2008b). Primary biliary cirrhosis is associated with a genetic variant in the 3′ flanking region of the CTLA4 gene. Gastroenterology, 135, 1200–6
   PubMed Web of Science ®Google Scholar
• Kanno Y, Rai T, Monoe K, et al. (2006). Possible association of cytotoxic T lymphocyte antigen-4 genetic polymorphism with liver damage of primary biliary cirrhosis in Japan. Fukushima J Med Sci, 52, 79–85
   PubMedGoogle Scholar
• Kavvoura FK, Akamizu T, Awata T, et al. (2007). Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: A meta-analysis. J Clin Endocrinol Metab, 92, 3162–70
   PubMed Web of Science ®Google Scholar
• Kristiansen OP, Larsen ZM, Pociot F. (2000). CTLA-4 in autoimmune diseases–a general susceptibility gene to autoimmunity? Genes Immun, 1, 170–84
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC, Choi SJ, et al. (2012). Association between the CTLA-4 +49 A/G polymorphism and susceptibility to rheumatoid arthritis: A meta-analysis. Mol Biol Rep, 39, 5599–605
   PubMed Web of Science ®Google Scholar
• Li M, Zheng H, Li T, et al. (2012). Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: A systematic review. J Gastroenterol Hepatol, 27, 1159–66
   PubMed Web of Science ®Google Scholar
• Li Q, Wang B, Pan F, et al. (2013). Association between cytotoxic T-lymphocyte antigen 4 gene polymorphisms and primary biliary cirrhosis in Chinese population: Data from a multicenter study. J Gastroenterol Hepatol, 28, 1397–402
   PubMed Web of Science ®Google Scholar
• Liu CP, Jiang JA, Wang T, et al. (2013). CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China. Genet Mol Res, 12, 1373–82
   PubMed Web of Science ®Google Scholar
• Mantaka A, Goulielmos GN, Koulentaki M, et al. (2012). Polymorphisms of genes related to endothelial cells are associated with primary biliary cirrhosis patients of Cretan origin. Hum Immunol, 73, 829–35
   PubMed Web of Science ®Google Scholar
• Miyake Y, Ikeda F, Takaki A, et al. (2011). +49A/G polymorphism of cytotoxic T-lymphocyte antigen 4 gene in type 1 autoimmune hepatitis and primary biliary cirrhosis: A meta-analysis. Hepatol Res, 41, 151–9
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med, 6, e1000097
   PubMed Web of Science ®Google Scholar
• Munafo MR, Flint J. (2004). Meta-analysis of genetic association studies. Trends Genet, 20, 439–44
   PubMed Web of Science ®Google Scholar
• Ngu JH, Wallace MC, Merriman TR, et al. (2013). Association of the HLA locus and TNF with type I autoimmune hepatitis susceptibility in New Zealand Caucasians. Springerplus, 2, 355
   Google Scholar
• Oertelt S, Kenny TP, Selmi C, et al. (2005). SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis. Clin Dev Immunol, 12, 259–63
   PubMedGoogle Scholar
• Poupon R, Ping C, Chretien Y, et al. (2008). Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol, 49, 1038–45
   PubMed Web of Science ®Google Scholar
• Schott E, Witt H, Pascu M, et al. (2007). Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease. Eur J Gastroenterol Hepatol, 19, 947–51
   PubMed Web of Science ®Google Scholar
• Song GG, Kim JH, Kim YH, Lee YH. (2013). Association between CTLA-4 polymorphisms and susceptibility to Celiac disease: A meta-analysis. Hum Immunol, 74, 1214–18
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. (2000). Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008–12
   PubMed Web of Science ®Google Scholar
• Sutherland RM, Brady JL, Georgiou HM, et al. (2000). Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts. Transplantation, 69, 1806–12
   PubMed Web of Science ®Google Scholar
• Takiguchi M, Murakami M, Nakagawa I, et al. (2000). Involvement of CD28/CTLA4-B7 costimulatory pathway in the development of lymphadenopathy and splenomegaly in MRL/lpr mice. J Vet Med Sci, 62, 29–36
   PubMed Web of Science ®Google Scholar
• Tang J, Zhou C, Zhang ZJ, Zheng SS. (2012). Association of polymorphisms in non-classic MHC genes with susceptibility to autoimmune hepatitis. Hepatobiliary Pancreat Dis Int, 11, 125–31
   PubMed Web of Science ®Google Scholar
• Umemura T, Ota M, Yoshizawa K, et al. (2008). Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese. Hepatol Res, 38, 689–95
   PubMed Web of Science ®Google Scholar
• van Gerven NM, de Boer YS, Zwiers A, et al. (2013). Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis. Liver Int, 33, 1039–43
   PubMed Web of Science ®Google Scholar
• Vigano P, Lattuada D, Somigliana E, et al. (2005). Variants of the CTLA4 gene that segregate with autoimmune diseases are not associated with endometriosis. Mol Hum Reprod, 11, 745–9
   PubMed Web of Science ®Google Scholar
• Vinay DS, Kim CH, Chang KH, Kwon BS. (2010). PDCA expression by B lymphocytes reveals important functional attributes. J Immunol, 184, 807–15
   PubMed Web of Science ®Google Scholar
• Walker EJ, Hirschfield GM, Xu C, et al. (2009). CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum, 60, 931–7
   PubMed Web of Science ®Google Scholar
• Yoshida O, Abe M, Furukawa S, et al. (2009). A familial case of autoimmune hepatitis. Intern Med, 48, 315–9
   PubMed Web of Science ®Google Scholar
• Zhai JX, Zou LW, Zhang ZX, et al. (2013). CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): A meta-analysis. Mol Biol Rep, 40, 5213–23
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang JS, Ma BL, Mamula MJ. (2002). Experimental autoimmune encephalomyelitis in the Wistar rat: Dependence of MBP-specific T cell responsiveness on B7 costimulation. Autoimmunity, 35, 191–9
   PubMed Web of Science ®Google Scholar